Investing in Psychedelics: Opportunities and Challenges for 2022

Presented by

Adrienne Rivlin, L.E.K., George Goldsmith - Compass Pathways, Sean McLintock, Clara Burtenshaw - Neo Kuma

About this talk

Psychedelics looks set to become the next major innovation in mental healthcare. This can be seen in the increasing number of successful clinical trials, ‘breakthrough’ regulatory designations, inward capital investment and evolving academic and public sentiment. However, some challenges remain. Join L.E.K.’s Healthcare and Life Sciences Partner, Dr. Adrienne Rivlin, George Goldsmith, Chairman, Chief Executive Officer, and Co founder, Compass Pathways and respected investors Sean McLintock and Clara Burtenshaw from Neo Kuma to learn how developed psychedelics is now, where the R&D, commercial and financial focus will be in 2022 and what major challenges still need to be overcome to successfully bring these medicines to market. The webinar will be interactive with plenty of opportunities to ask questions and learn from academic, industry and investor experts. What will you learn? • What scientific, clinical and financial opportunities and challenges exist in psychedelics? • Who are the major players and stakeholders in this space now? • How is psychedelics likely to evolve in the future? Who should attend? • C-suite and heads of strategy who want to understand the opportunities and challenges in psychedelics • R&D teams analysing advances in psychedelics research • Finance and Commercial Directors seeking to better understand this area • M&A and Business Development professionals who want to qualify opportunities
Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (104)
Subscribers (7592)
We combine deep expertise with rigorous analysis to help business leaders navigate their markets, make the most of opportunities, and deliver better returns. Some of the world’s most sophisticated, innovative, and successful organisations choose us to help them maximise their potential. Visit us online at and follow us on Twitter, Facebook, LinkedIn and Instagram to meet more of our talented team and learn about the challenges we are helping clients overcome.